Raffaele Baffa
Director Técnico/Científico/I+D en CARSGEN THERAPEUTICS HOLDINGS LIMITED .
Perfil
Raffaele Baffa's career history includes current and former positions as well as education.
Currently, he is the Chief Medical Officer at CARsgen Therapeutics Holdings Ltd.
Previously, he held positions such as Director-Urology Research at Genito Urinary Medical Oncologists of Canada Gumo, Head-Translational Sciences at Sanofi, Inc., Vice President at Shire Pharmaceuticals LLC, Chief Medical Officer at Servier Pharmaceuticals LLC, and Chief Medical Officer at Alaunos Therapeutics, Inc. He also served as the Chief Medical Officer at Medisix Therapeutics, Inc. Dr. Baffa's education includes a doctorate from Providence College & Theological Seminary and the University of Parma.
Cargos activos de Raffaele Baffa
| Empresas | Cargo | Inicio |
|---|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Director Técnico/Científico/I+D | 07/04/2022 |
Antiguos cargos conocidos de Raffaele Baffa.
| Empresas | Cargo | Fin |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/04/2022 |
Servier Pharmaceuticals LLC
 Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company, based in Boston, MA, was founded in 1954. Servier Pharmaceuticals is committed to innovation and improving the lives of patients, their families, and caregivers. The company invests in research and development to address the unmet needs of patients, particularly in the areas of oncology, cardiovascular diseases, cancers, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. The company offers financial assistance to support patients, advocacy groups, and healthcare professionals. The company strives for transparency in clinical trials and research and development. Servier Pharmaceuticals aims to create a brighter future for all by providing life-saving treatments to a greater number of patients. The company actively seeks alliances, acquisitions, licensing deals, and partnerships to accelerate access to therapies. David K. Lee has been the CEO of the company since 2018. | Director Técnico/Científico/I+D | 01/03/2020 |
Shire Pharmaceuticals LLC
 Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Corporate Officer/Principal | 01/09/2018 |
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Corporate Officer/Principal | 01/02/2018 |
| Genito Urinary Medical Oncologists of Canada Gumo | Corporate Officer/Principal | - |
Formación de Raffaele Baffa.
| University of Parma | Doctorate Degree |
| Providence College & Theological Seminary | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Health Technology |
| Empresas privadas | 5 |
|---|---|
Medisix Therapeutics, Inc.
 Medisix Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Medisix Therapeutics, Inc. develops novel cellular therapies to address T cell malignancies. The company is headquartered in Singapore. | Commercial Services |
Servier Pharmaceuticals LLC
Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company, based in Boston, MA, was founded in 1954. Servier Pharmaceuticals is committed to innovation and improving the lives of patients, their families, and caregivers. The company invests in research and development to address the unmet needs of patients, particularly in the areas of oncology, cardiovascular diseases, cancers, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. The company offers financial assistance to support patients, advocacy groups, and healthcare professionals. The company strives for transparency in clinical trials and research and development. Servier Pharmaceuticals aims to create a brighter future for all by providing life-saving treatments to a greater number of patients. The company actively seeks alliances, acquisitions, licensing deals, and partnerships to accelerate access to therapies. David K. Lee has been the CEO of the company since 2018. | Health Technology |
Shire Pharmaceuticals LLC
Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Health Technology |
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
| Genito Urinary Medical Oncologists of Canada Gumo |
- Bolsa de valores
- Insiders
- Raffaele Baffa
